|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2002-9-19
|
|
pubmed:abstractText |
We undertook a prospective phase II study to assess the feasibility and activity of a new induction chemotherapy regimen followed by hyperfractionated irradiation in locally advanced squamous cell head and neck cancer.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0030-2414
|
|
pubmed:author |
pubmed-author:CatalanoGianpieroG,
pubmed-author:ChiesaFaustoF,
pubmed-author:De BraudFilippoF,
pubmed-author:De PaoliFioraF,
pubmed-author:De PasTommasoT,
pubmed-author:DePasTommasoT,
pubmed-author:Jereczek-FossaBarbara ABA,
pubmed-author:KrengliMarcoM,
pubmed-author:MarroccoEmanuelaE,
pubmed-author:MasciGiovannaG,
pubmed-author:OrecchiaRobertoR,
pubmed-author:RobertsonChrisC,
pubmed-author:VavassoriAndreaA
|
|
pubmed:copyrightInfo |
Copyright 2002 S. Karger AG, Basel
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
63
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
115-23
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:12239445-Adolescent,
pubmed-meshheading:12239445-Adult,
pubmed-meshheading:12239445-Aged,
pubmed-meshheading:12239445-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:12239445-Cisplatin,
pubmed-meshheading:12239445-Combined Modality Therapy,
pubmed-meshheading:12239445-Disease-Free Survival,
pubmed-meshheading:12239445-Dose Fractionation,
pubmed-meshheading:12239445-Female,
pubmed-meshheading:12239445-Fluorouracil,
pubmed-meshheading:12239445-Head and Neck Neoplasms,
pubmed-meshheading:12239445-Humans,
pubmed-meshheading:12239445-Infusions, Intravenous,
pubmed-meshheading:12239445-Magnetic Resonance Imaging,
pubmed-meshheading:12239445-Male,
pubmed-meshheading:12239445-Middle Aged,
pubmed-meshheading:12239445-Neoplasm Staging,
pubmed-meshheading:12239445-Neutropenia,
pubmed-meshheading:12239445-Survival Rate,
pubmed-meshheading:12239445-Time Factors,
pubmed-meshheading:12239445-Vinblastine
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Phase II trial of vinorelbine, cisplatin and continuous infusion of 5-fluorouracil followed by hyperfractionated radiotherapy in locally advanced head and neck cancer.
|
|
pubmed:affiliation |
Division of Radiotherapy, European Institute of Oncology, Milan, Italy. roberto.orecchia@ieo.it
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study,
Clinical Trial, Phase II
|
